Hong Kong IPO disclosure precedents · 311 companies, 348 items
one-off or non-recurring items that move the results: bargain-purchase gains, disposal gains, large exchange losses, a sharp fall in VAT refunds or grants that swings other income
However, in FY2023, our Group and the customer mutually agreed to terminate the contract in view of the change in work scope.
Business · p. 157
As the termination constituted a contract modification within the meaning of the relevant accounting standards, we reversed the relevant revenue of approximately RM2.0 million in FY2023.
Business · p. 157
Our Group has implemented and will continue to strengthen the following internal control procedures and risk-mitigation measures to prevent the recurrence of revenue reversals similar to the isolated case described above: (i) prior to the commencement of any works, including preliminary or design-related activities, our project directors are required to review and confirm that a formally executed contract or other legally binding documentation is in place.
As a result, the shareholders' meeting of Jiangxi Tungsten Jinxun Resources Africa SAS unanimously held that the company to cease operations from December 31, 2023.
Financial Information · p. 310
Accordingly, the relevant principle and interest have been written-off and were excluded from being recognized as relevant interest income in 2024.
Financial Information · p. 310
an impairment loss on financial assets under ECL, representing the impairment made to a loan provided to an associate, Jiangxi Tungsten Jinxun Resources Africa SAS.
Our other gains/(losses), net primarily consists of deemed gain on disposal of subsidiaries and associates, net gain on disposal of financial assets at fair value through profit or loss (“FVPL”) and net fair value (losses)/gains on financial assets at FVPL.
Financial Information · p. 311
For the years ended December 31, 2022, 2023 and 2024, and for the six months ended June 30, 2024 and 2025, the other gains/(losses), net represented 3.7%, 1.7%, 1.1%, nil and 0.1% of our total revenue, respectively.
Financial Information · p. 311
Our other gains, net decreased by 53.1% from RMB745.3 million in 2022 to RMB349.3 million in 2023, primarily due to the fluctuation of fair value of our investments.
In 2023, we recorded other net losses of RMB35.3 million, primarily arising from (i) a net foreign exchange losses of RMB19.7 million, mainly resulting from the fluctuations between ZMW and U.S. dollar arising from input VAT recoverable in Zambia; and (ii) an impairment loss on financial assets under ECL, representing the impairment made to a loan provided to an associate, Jiangxi Tungsten Jinxun Resources Africa SAS.
Financial Information · p. 311
an increase of RMB10.3 million in impairment losses on VAT receivables, primarily due to prolonged tax refund process in Zambia
In 2024, we recognized income tax benefit of RMB5.8 million, primarily due to the reversal of provision for uncertain taxes that arose from certain tax benefits we claimed in the U.S.
Financial Information · p. 312
These reversals were recorded as a reduction to our 2024 provision for income taxes.
Other income decreased by 18.3% from RMB519.3 million in 2022 to RMB424.4 million in 2023, primarily due to a decrease in gain from foreign exchange differences of RMB165.8 million primarily attributable to fluctuation in exchange rate between USD to RMB, which was partially offset by an increase in interest income of RMB81.2 million as a result of an increase in deposits with banks.
Financial Information · p. 279
Other income increased by 29.6% from RMB424.4 million in 2023 to RMB549.9 million in 2024, primarily due to (i) a RMB95.8 million increase in interest income in 2024 primarily due to the increase in our deposits with banks, and (ii) a RMB101.5 million increase in gains from foreign exchange difference mainly as a result of fluctuations in exchange rate from USD to RMB.
Our other net gain increased from RMB18.6 million in 2023 to RMB44.2 million in 2024, primarily attributable to an increase in government grants of RMB29.8 million.
Financial Information · p. 469
Government grants mainly represent incentives received from the government for the purpose of compensation on research and development activities.
Impairment loss on financial assets significantly increased from RMB0.03 million in 2022 to RMB19.8 million in 2023 due to an one-time write-off of other receivables in 2023.
Financial Information · p. 267
Impairment loss on financial assets decreased by 14.0%, from RMB19.8 million in 2023 to RMB17.0 million in 2024, due to an one-time write-off of other receivables in 2023.
Financial Information · p. 264
Our other income increased from RMB10.0 million in 2023 to RMB19.3 million in 2024, primarily due the net gain on disposal of property and equipment and intangible assets.
Our other income and gains decreased from RMB33.8 million in 2022 to RMB20.1 million in 2023, primarily due to a decrease of RMB14.1 million in foreign exchange gains.
As direct consequences of this BIS Listing, we recorded special losses on certain assets of RMB108.7 million in 2023, including those related to prepayments, intangible assets, inventories and property, plant and equipment.
Financial Information · p. 354
In recognizing these special losses, we take a conservative approach and made impairment on all assets with potential recoverability issues due to the BIS Listing.
Recovery of trade receivables written off in prior year | — | 6,540 | — | — | —
Financial Information · p. 382
For the year ended December 31, 2023, we recorded other gains of RMB3.7 million, compared to a loss of RMB0.5 million for the year ended December 31, 2022.
Financial Information · p. 397
For the year ended December 31, 2024, we recorded other gains of RMB10.3 million compared to gains of RMB3.7 million for the year ended December 31, 2023, primarily attributable to our disposal of USAS Tianjin in November 2024.
In October 2022, we disposed of 100% equity interest of its wholly owned subsidiary InSilico LLC to an independent third party.
Financial Information · p. 395
Our other losses, net, significantly improved from US$3.8 million for 2022 to other gains, net at US$0.3 million for 2023, which was primarily attributable to (i) an equity investment in Regent Pacific Group Limited, for further information about this equity investment, see Note 19 to the Accountants’ Report in Appendix I to this Prospectus, and (ii) a disposal of a subsidiary.
This increase was primarily due to the recognition of a net foreign exchange gain of RMB6.1 million, which was mainly attributable to the appreciation of the Japanese Yen against the Renminbi during the period, as a significant portion of our revenue was denominated in Japanese Yen.
The fair value gains on FVTPL represent variable consideration of equity interests transfer in Taizhou Hanzhong to Lepu.
Financial Information · p. 471
The decrease was primarily because no fair value gains on FVTPL for the variable consideration resulted from disposal of our equity interest in Taizhou Hanzhong was recognized in 2025.
Financial Information · p. 476
We incurred income tax expense of RMB12.5 million for the eight months ended August 31, 2025, while we recorded income tax credit of RMB12.0 million for the eight months ended August 31, 2024, primarily due to the increase of RMB2.7 million in deferred tax resulted from fluctuation of the variable consideration arising from disposal of our equity interest in Taizhou Hanzhong to Lepu.
This was mainly because: (i) certain input VAT invoices for 2022 were only received by us in early 2023 and used for VAT refund declaration in 2023, which let to more input VAT deducted in 2023 and consequently lower VAT collected with lower amount of VAT refund granted as compared to 2022, and (ii) we also deferred declaration for certain VAT refund for 2023 to 2024 as our Company was in the process of changing its administrative district in 2023, which resulted in more VAT refund received in 2024 as compared to 2023.
Financial Information · p. 394
This decrease was primarily due to the decrease in value-added tax refund by 78.4% to RMB3.5 million for the year ended December 31, 2023 from RMB16.3 million for the year ended December 31, 2022.
Financial Information · p. 408
This increase was primarily due to the increase in value-added tax refund by 471.4% to RMB20.2 million for the year ended December 31, 2024 from RMB3.5 million for the year ended December 31, 2023.
Our other net gain decreased significantly from RMB12.0 million in 2022 to RMB1.5 million in 2023, mainly as (i) we received a one-off award of RMB10.0 million in 2022 for our Nanjing BenQ Hospital attaining a Grade A Class III hospital rating;
Financial Information · p. 391
Our other net gain primarily consisted of (i) government grants, mainly representing one-off and unconditional subsidies that we received from government authorities to support our discipline development.
Other gains increased by approximately RMB9.4 million, or 2,350% from approximately RMB0.4 million for the year ended 31 December 2022 to approximately RMB9.8 million for the year ended 31 December 2023, primarily attributable to an increase in our gain on extension of repayment of mining rights granting fees payables and gain on fair value changes of financial assets at FVTPL.
Financial Information · p. 312
Other gains decreased by approximately RMB9.3 million, or 94.9% from approximately RMB9.8 million for the year ended 31 December 2023 to approximately RMB0.5 million for the year ended 31 December 2024, primarily attributable to the one-off gain on an extension of repayment of mining right granting fee payable of RMB8.2 million that was only recognised in 2023.
Our other gains, net increased by 382.9% from HK$8.3 million in 2023 to HK$39.9 million in 2024, primarily attributable to the significant increase in net recovery of ECL for trade receivables from nil in 2023 to HK$55.8 million in 2024, mainly attributable to the improvement of digital asset market conditions and our enhanced recollection efforts.
Financial Information · p. 437
the decrease of ECL allowances from HK$59.1 million as of December 31, 2023 to HK$3.3 million as of December 31, 2024, mainly due to settlement of certain ECL allowances as a result of the improvement of digital asset market conditions and our enhanced recollection efforts.
Our other income and gains increased by 228.3% from RMB4.6 million for the six months ended June 30, 2024 to RMB15.1 million for the six months ended June 30, 2025.
Financial Information · p. 364
Such increase was primarily due to (i) an increase in our gains on foreign exchange, resulting from the appreciation of the British pound, US dollar, and euro in the first half of 2025; and (ii) an increase in our government grants, including talent subsidies and funding for technology projects.
We recorded other gains of RMB3.6 million in 2023, compared to other losses of RMB36.5 million in 2022, primarily due to our one-off incurrence of gain on repurchase of convertible preferred shares of RMB77.7 million in 2023, partially offset by an increase of RMB32.2 million in net loss from fair value changes of equity investments in unlisted entities measured as financial assets at fair value through profit or loss in connection with our equity investment in certain investees.
Financial Information · p. 330
We recorded other losses of RMB25.2 million in 2024, compared to other gains of RMB3.6 million in 2023, primarily due to an increase in net loss from fair value changes of equity investments in unlisted entities measured as financial assets at fair value through profit or loss of RMB80.9 million in connection with our equity investment in certain investees in 2024 and our one-off incurrence of gain on repurchase of convertible preferred shares of RMB77.7 million in 2023, which we did not have in 2024, partially offset by our incurrence of loss on redesignation of convertible preferred shares of RMB45.3 million in 2023, which we did not have in 2024.